MMSI (Merit Medical Systems) 3-Month Share Buyback Ratio: -0.09% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MMSI Merit Medical Systems Inc MMSI
84 GF Score
Price $89.04
GF Value $95.78
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Merit Medical Systems 3-Month Share Buyback Ratio?

Merit Medical Systems MMSI +1.59% 84 3-Month Share Buyback Ratio is -0.09 as of Jun. 2026. GuruFocus rates MMSI with a GF Score™ of 84/100 and a GF Value™ of $95.78 (Fairly Valued). The stock has 1 warning sign investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Merit Medical Systems's current 3-Month Share Buyback Ratio was -0.09%.


Merit Medical Systems  (NAS:MMSI) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Merit Medical Systems 3-Month Share Buyback Ratio Related Terms


MMSI vs NVST, MMED, ICUI: 3-Month Share Buyback Ratio Comparison

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems 3-Month Share Buyback Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's 3-Month Share Buyback Ratio falls into.


MMSI
84GF Score
Merit Medical Systems Inc MMSI
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merit Medical Systems 3-Month Share Buyback Ratio Calculation

Merit Medical Systems's 3-Month Share Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Mar. 2026 ) - Shares Outstanding (EOP) (Jun. 2026 )) / Shares Outstanding (EOP) (Mar. 2026 )
=(59.655 - 59.710) / 59.655
=-0.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 3-Month Share Buyback Ratio of -0.09 mean?
Merit Medical Systems (MMSI) has a 3-Month Share Buyback Ratio of -0.09 as of Jun. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Merit Medical Systems and its competitors.
Is Merit Medical Systems' 3-Month Share Buyback Ratio too high?
Merit Medical Systems' current 3-Month Share Buyback Ratio is -0.09. Overall, Merit Medical Systems has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' 3-Month Share Buyback Ratio compare to NVST and MMED?
Merit Medical Systems' 3-Month Share Buyback Ratio of -0.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Merit Medical Systems and its competitors. Merit Medical Systems's current 3-Month Share Buyback Ratio is -0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (MMSI) is currently considered Fairly Valued. The stock's GF Value™ is $95.78, compared to a current price of $89.04 — trading 7% below its estimated fair value. The current 3-Month Share Buyback Ratio is -0.09. Merit Medical Systems' overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Merit Medical Systems (MMSI), the current 3-Month Share Buyback Ratio is -0.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merit Medical Systems (MMSI) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of $89.04 is trading 7% below its estimated GF Value™ of $95.78. GuruFocus considers Merit Medical Systems to be Fairly Valued.

Key valuation signals for MMSI:

  • 3-Month Share Buyback Ratio: -0.09
  • GF Value™: $95.78 vs. price of $89.04 (7% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the MMSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merit Medical Systems Business Description

Other Exchanges MM3:Germany
Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
84GF Score

Get the complete analysis for MMSI

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$89.04
Price
$95.78
GF Value